Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal APL-2 for Patients With Wet AMD (ASAP II)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02461771
Recruitment Status : Completed
First Posted : June 3, 2015
Last Update Posted : June 9, 2016
Sponsor:
Information provided by (Responsible Party):
Apellis Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2016
Actual Study Completion Date : May 2016
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 August 4, 2020